Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Poult Sci ; 92(10): 2644-50, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24046411

RESUMEN

In an effort to explore strategies to control Clostridium perfringens, we investigated the synergistic effect of a ubiquitous bacterial second messenger 3',5'-cyclic diguanylic acid (c-di-GMP) with penicillin G in a broiler challenge model. All chicks were inoculated in the crop by gavage on d 14, 15, and 16 with a mixture of 4 C. perfringens strains. Birds were treated with saline (control group) or 20 nmol of c-di-GMP by gavage or intramuscularly (IM) on d 24, all in conjunction with penicillin G in water for 5 d. Weekly samplings of ceca and ileum were performed on d 21 to 35 for C. perfringens and Lactobacillus enumeration. On d 35 of age, the IM treatment significantly (P < 0.05) reduced C. perfringens in the ceca, suggesting possible synergistic activity between penicillin G and c-di-GMP against C. perfringens in broiler ceca. Moreover, analysis of ceca DNA for the presence of a series of C. perfringens virulence genes showed a prevalence of 30% for the Clostridium perfringens alpha-toxin gene (cpa) from d 21 to 35 in the IM-treated group, whereas the occurrence of the cpa gene increased from 10 to 60% in the other 2 groups (control and gavage) from d 21 to 35. Detection of ß-lactamase genes (blaCMY-2, blaSHV, and blaTEM) indicative of gram-negative bacteria in the same samples from d 21 to 35 did not show significant treatment effects. Amplified fragment-length polymorphism showed a predominant 92% similarity between the ceca of 21-d-old control birds and the 35-d-old IM-treated c-di-GMP group. This suggests that c-di-GMP IM treatment might be effective at restoring the normal microflora of the host on d 35 after being challenged by C. perfringens. Our results suggest that c-di-GMP can reduce the colonization of C. perfringens in the gut without increasing the selection pressure for some ß-lactamase genes or altering the commensal bacterial population.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Pollos , Infecciones por Clostridium/veterinaria , Clostridium perfringens/efectos de los fármacos , GMP Cíclico/análogos & derivados , Enteritis/veterinaria , Enfermedades de las Aves de Corral/inmunología , Adyuvantes Inmunológicos/administración & dosificación , Alimentación Animal/análisis , Animales , Antibacterianos/administración & dosificación , Antibacterianos/farmacología , Toxinas Bacterianas/genética , Toxinas Bacterianas/metabolismo , Ciego/microbiología , Infecciones por Clostridium/tratamiento farmacológico , Infecciones por Clostridium/inmunología , Clostridium perfringens/patogenicidad , Recuento de Colonia Microbiana/veterinaria , GMP Cíclico/administración & dosificación , GMP Cíclico/farmacología , Nutrición Enteral/veterinaria , Enteritis/tratamiento farmacológico , Enteritis/inmunología , Inyecciones Intramusculares/veterinaria , Masculino , Penicilina G/administración & dosificación , Penicilina G/farmacología , Reacción en Cadena de la Polimerasa/veterinaria , Enfermedades de las Aves de Corral/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA